Modification of brain mitochondrial monoamine oxidase activities by hydroxyethylhydrazide of cyanoacetic acid and some other monoamine oxidase inhibitors.
D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism; D001921:Brain / Q000201:enzymology* / Q000648:ultrastructure; D002103:Cadaverine / Q000378:metabolism; D002417:Cattle; D006834:Hydrazines / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007700:Kinetics; D008928:Mitochondria / Q000187:drug effects / Q000201:enzymology*; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009570:Nitriles / Q000494:pharmacology; D013997:Time Factors
D001679:Biogenic Amines; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D009570:Nitriles; D008995:Monoamine Oxidase; D002103:Cadaverine